Intercept Pharmaceuticals | Custo De Mercadoria Vendida



Cost Of Sales Alterar Data
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amarin USD 16.89M 18.51M 2025-03
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Biogen USD 629.3M 45.8M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
PTC Therapeutics USD 12.86M 3.42M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Intercept Pharmaceuticals Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.